STA
CELG

Summit Trail Advisors’s Celgene Corp CELG Stock Holding History

Summit Trail Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,884
Closed -$235K – 735
2018
Q1 		$235K Buy
2,884
+315
+12% +$30.2K 0.04% 337
2017
Q4 		$265K Buy
+2,569
New +$290K 0.03% 352

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Trail Advisors's CELG Position: Q2 2018 in Review

Summit Trail Advisors sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 2,884 shares — an estimated $235K sold.

Summit Trail Advisors first reported a position in CELG in Q4 2017 and held it in 2 quarters. The position peaked at $265K in Q4 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Summit Trail Advisors reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 2,884 Celgene Corp shares in Q2 2018, an estimated $235K.
  • Summit Trail Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 2 quarters.
  • Summit Trail Advisors's Celgene Corp position peaked at $265K in Q4 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Summit Trail Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.